BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9705871)

  • 1. Inhibition of clotting factor XIII activity by nitric oxide.
    Catani MV; Bernassola F; Rossi A; Melino G
    Biochem Biophys Res Commun; 1998 Aug; 249(1):275-8. PubMed ID: 9705871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level.
    Andrew PJ; Harant H; Lindley IJ
    Biochem Biophys Res Commun; 1995 Sep; 214(3):949-56. PubMed ID: 7575568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease.
    Venturini G; Colasanti M; Salvati L; Gradoni L; Ascenzi P
    Biochem Biophys Res Commun; 2000 Jan; 267(1):190-3. PubMed ID: 10623597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid.
    Percival MD; Ouellet M; Campagnolo C; Claveau D; Li C
    Biochemistry; 1999 Oct; 38(41):13574-83. PubMed ID: 10521264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro.
    Beauvais F; Michel L; Dubertret L
    J Cell Physiol; 1995 Dec; 165(3):610-4. PubMed ID: 7593240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide and prostaglandins in mechanically induced bone formation.
    Chow JW; Fox SW; Lean JM; Chambers TJ
    J Bone Miner Res; 1998 Jun; 13(6):1039-44. PubMed ID: 9626636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
    Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
    Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
    Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
    Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components.
    Yao J; Schoecklmann HO; Pröls F; Gauer S; Sterzel RB
    Kidney Int; 1998 Mar; 53(3):598-608. PubMed ID: 9507204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation sensitisation by nitric oxide releasing agents.
    Mitchell JB; Cook JA; Krishna MC; DeGraff W; Gamson J; Fisher J; Christodoulou D; Wink DA
    Br J Cancer Suppl; 1996 Jul; 27():S181-4. PubMed ID: 8763876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F.
    Cunningham JM; Mabley JG; Delaney CA; Green IC
    Mol Cell Endocrinol; 1994 Jun; 102(1-2):23-9. PubMed ID: 7926270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures.
    Nisoli E; Clementi E; Tonello C; Sciorati C; Briscini L; Carruba MO
    Br J Pharmacol; 1998 Oct; 125(4):888-94. PubMed ID: 9831929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the mechanism of erythrocyte Na+/K+-ATPase inhibition by nitric oxide and peroxynitrite anion.
    Muriel P; Castañeda G; Ortega M; Noël F
    J Appl Toxicol; 2003; 23(4):275-8. PubMed ID: 12884412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide inactivates rat hepatic methionine adenosyltransferase In vivo by S-nitrosylation.
    Ruiz F; Corrales FJ; Miqueo C; Mato JM
    Hepatology; 1998 Oct; 28(4):1051-7. PubMed ID: 9755242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide inhibition of tobacco catalase and ascorbate peroxidase.
    Clark D; Durner J; Navarre DA; Klessig DF
    Mol Plant Microbe Interact; 2000 Dec; 13(12):1380-4. PubMed ID: 11106031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of tubulin cysteines by nitric oxide and nitroxyl donors alters tubulin polymerization activity.
    Landino LM; Koumas MT; Mason CE; Alston JA
    Chem Res Toxicol; 2007 Nov; 20(11):1693-700. PubMed ID: 17907787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.